Latest news

Neuralink Secures FDA Approval for Human Clinical Study of Brain Implants

In a ground-breaking development, Elon Musk's Neuralink has received approval from the US Food and Drug Administration (FDA) to commence human clinical trials for their revolutionary brain implant technology. This pivotal milestone marks a significant leap forward in the field of neurotechnology, opening doors to a future where humans can interface directly with computers and potentially overcome neurological disorders. With the FDA's endorsement, Neuralink is poised to embark on an exciting journey toward unlocking the full potential of the human brain.

Read more

Great news from pharmaceutical companies

Many pharmaceutical companies made nice profit or even a fortune during the Covid pandemic. However, now that pandemic is relatively over, they will have to find a new way to earn money, since Covid vaccines will not be selling as much as they did. And these companies proved, that they already have plans for future development, so let’s check what they are up to.

Read more

Looming crisis due to the US debt ceiling increase

Banks and asset managers on Wall Street are bracing for the consequences of a potential default. Although the financial industry has faced similar crises in the past, the short timeframe to reach a compromise makes bankers nervous. This article examines the potential consequences of a U.S. default and highlights the preparations that financial institutions are making.

Read more

Stable gold prices in a time of uncertainty

For millennia, gold has been seen as a jewel among metals, not only because of its aesthetic value but also because it is one of the oldest and most reliably preserved sources of wealth. This precious metal has become a popular investment commodity and an attraction for many investors and traders. But what about today, in times of uncertainty and volatility in world markets?

Read more

Manage Cookies

Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 73.31% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.